Virtus LifeSci Biotech Pr... (BBP)
Virtus LifeSci Biotech Products ETF Max Pain By Strike
BBP trades at $67.16, 17.8% above the near-term max pain of $57 expiring Sep 19, 2025 (21 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($49-$95), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Virtus LifeSci Biotech Products ETF Max Pain By Expiry
Max pain for BBP shows a downward trend from 95 to 49, indicating bearish sentiment or hedging activity. The 70% spread signals divergent expectations across timeframes. Levels distributed around 67.16. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 57 | -10.16 (-15.13%) |
| Oct 17, 2025 | 50 | -17.16 (-25.55%) |
| Jan 16, 2026 | 49 | -18.16 (-27.04%) |
| Apr 17, 2026 | 59 | -8.16 (-12.15%) |
| Dec 18, 2026 | 95 | 27.84 (41.45%) |
| Jan 1, 2031 | 83.33 | 16.17 (24.08%) |